• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Rucaparib
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    RUBRACA 200 mg, 250 mg, 300 mg
    full basket chart
    RUBRACA 200 mg, 250 mg, 300 mg

    PARP inhibitor. Rucaparib 200mg, 250mg, 300mg.
    F. C. TAB.:60. The recom. dose is 600 mg (two 300 mg tabs.) taken orally twice dly. with / without food.
    Cont. tmt. until dis. progress. or unaccept. toxic.
    If a pt. misses a dose, instruct the pt. to take the next dose at its scheduled time. Vomited doses should not be replaced.
    To manage adverse reactions, consider interruption of tmt. or dose reduct.
    Recom.dose reductions: Starting Dose:  600 mg ×2/d(two 300 mg tab.).
    1st Dose Reduct.: 500 mg ×2/d (two 250 mg tab.).
    2nd  Dose Reduct.: 400 mg ×2/d (two 200 mg tab.).
    3rd  Dose Reduct.: 300 mg ×2/d (one 300 mg tab.).
    Indicated for the maint. tmt. of adult pts. with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemother.
    Tmt. of adult pts. with deleterious BRCA mutat. (germline and/or somatic)-assoc. epithelial ovarian, fallopian tube, or prim. peritoneal cancer who have been treated with two or more chemotherapies.
    C/I: Hypersens.